Viewing Study NCT01259856


Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2025-12-25 @ 9:17 PM
Study NCT ID: NCT01259856
Status: COMPLETED
Last Update Posted: 2019-04-30
First Post: 2010-12-07
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)
Sponsor: Ronald Hoffman
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: GCO 09-1300-00002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NETWORK View
None NIH View
None INDUSTRY View